Risk of Solid Organ and Hematological Malignancy in Patients With Inflammatory Bowel Diseases

被引:0
|
作者
Kappelman, Michael
Farkas, Dora K.
Erichsen, Rune
Pedersen, Lars
Sandler, Robert S.
Baron, John A.
Sorensen, Henrik T.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S41 / S41
页数:1
相关论文
共 50 条
  • [21] Thiopurines do not increase risk of malignancy in Taiwan patients with inflammatory bowel diseases: A nationwide population-based study
    Chen Yen-Nien
    Hsu Wen-Fen
    Chang Li-Chun
    Tu Chia-Hung
    Wu Ming-Shiang
    Chiu Han-Mo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 69 - 69
  • [22] Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
    Halling, Morten L.
    Kjeldsen, Jens
    Knudsen, Torben
    Nielsen, Jan
    Hansen, Lars Koch
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (33) : 6137 - 6146
  • [23] Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
    Ananthakrishnan, Ashwin N.
    Cheng, Su-Chun
    Cai, Tianxi
    Cagan, Andrew
    Gainer, Vivian S.
    Szolovits, Peter
    Shaw, Stanley Y.
    Churchill, Susanne
    Karlson, Elizabeth W.
    Murphy, Shawn N.
    Kohane, Isaac
    Liao, Katherine P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) : 1342 - +
  • [24] Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
    Morten L Halling
    Jens Kjeldsen
    Torben Knudsen
    Jan Nielsen
    Lars Koch Hansen
    World Journal of Gastroenterology, 2017, (33) : 6137 - 6146
  • [25] Risk factors of infection in patients with hematological malignancy
    Kawada, Tomoyuki
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2251 - 2251
  • [26] Risk factors of infection in patients with hematological malignancy
    Tomoyuki Kawada
    Annals of Hematology, 2019, 98 : 2251 - 2251
  • [27] MALIGNANCY RISK IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY
    Gandle, Cassandra
    Hou, Jason K.
    GASTROENTEROLOGY, 2019, 156 (03) : S48 - S48
  • [28] The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
    Dulai, Parambir S.
    Siegel, Corey A.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 525 - +
  • [29] MALIGNANCY RISK IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY
    Gandle, Cassandra
    Hou, Jason K.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S33 - S33
  • [30] IS THERE A CARDIOVASCULAR RISK IN INFLAMMATORY BOWEL DISEASES?
    Mitu, O.
    Alexandrescu, D. M.
    Mihai, Catalina
    Cijevschi-Prelipcean, Cristina
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2014, 118 (04): : 918 - 923